Global HER2-negative Breast Cancer Market Research Report 2016

Global HER2-negative Breast Cancer Market Research Report 2016

1 HER2-negative Breast Cancer Market Overview

1.1 Product Overview and Scope of HER2-negative Breast Cancer

1.2 HER2-negative Breast Cancer Segment by Type

1.2.1 Global Production Market Share of HER2-negative Breast Cancer by Type in 2015

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 HER2-negative Breast Cancer Segment by Application

1.3.1 HER2-negative Breast Cancer Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 HER2-negative Breast Cancer Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of HER2-negative Breast Cancer (2011-2021)

2 Global HER2-negative Breast Cancer Market Competition by Manufacturers

2.1 Global HER2-negative Breast Cancer Production and Share by Manufacturers (2015 and 2016)

2.2 Global HER2-negative Breast Cancer Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global HER2-negative Breast Cancer Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers HER2-negative Breast Cancer Manufacturing Base Distribution, Sales Area and Product Type

2.5 HER2-negative Breast Cancer Market Competitive Situation and Trends

2.5.1 HER2-negative Breast Cancer Market Concentration Rate

2.5.2 HER2-negative Breast Cancer Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global HER2-negative Breast Cancer Production, Revenue (Value) by Region (2011-2016)

3.1 Global HER2-negative Breast Cancer Production and Market Share by Region (2011-2016)

3.2 Global HER2-negative Breast Cancer Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

4 Global HER2-negative Breast Cancer Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global HER2-negative Breast Cancer Consumption by Regions (2011-2016)

4.2 North America HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India HER2-negative Breast Cancer Production, Consumption, Export, Import by Regions (2011-2016)

5 Global HER2-negative Breast Cancer Production, Revenue (Value), Price Trend by Type

5.1 Global HER2-negative Breast Cancer Production and Market Share by Type (2011-2016)

5.2 Global HER2-negative Breast Cancer Revenue and Market Share by Type (2011-2016)

5.3 Global HER2-negative Breast Cancer Price by Type (2011-2016)

5.4 Global HER2-negative Breast Cancer Production Growth by Type (2011-2016)

6 Global HER2-negative Breast Cancer Market Analysis by Application

6.1 Global HER2-negative Breast Cancer Consumption and Market Share by Application (2011-2016)

6.2 Global HER2-negative Breast Cancer Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global HER2-negative Breast Cancer Manufacturers Profiles/Analysis

7.1 F. Hoffmann-La Roche

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 F. Hoffmann-La Roche HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Novartis

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Novartis HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Pfizer

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Pfizer HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 AbbVie

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 AbbVie HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 AstraZeneca

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 AstraZeneca HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 BioMarin

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 BioMarin HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Bristol-Myers Squibb

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Bristol-Myers Squibb HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 Eisai

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 Eisai HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Eli Lilly

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Eli Lilly HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 Galena Biopharma

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 HER2-negative Breast Cancer Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 Galena Biopharma HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

7.11 Incyte

7.12 Merck

7.13 Merck Serono

7.14 Merrimack

7.15 Nektar

7.16 Tesaro

8 HER2-negative Breast Cancer Manufacturing Cost Analysis

8.1 HER2-negative Breast Cancer Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of HER2-negative Breast Cancer

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 HER2-negative Breast Cancer Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global HER2-negative Breast Cancer Market Forecast (2016-2021)

12.1 Global HER2-negative Breast Cancer Production, Revenue Forecast (2016-2021)

12.2 Global HER2-negative Breast Cancer Production, Consumption Forecast by Regions (2016-2021)

12.3 Global HER2-negative Breast Cancer Production Forecast by Type (2016-2021)

12.4 Global HER2-negative Breast Cancer Consumption Forecast by Application (2016-2021)

12.5 HER2-negative Breast Cancer Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of HER2-negative Breast Cancer

Figure Global Production Market Share of HER2-negative Breast Cancer by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table HER2-negative Breast Cancer Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2011-2021)

Figure China HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2011-2021)

Figure India HER2-negative Breast Cancer Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global HER2-negative Breast Cancer Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global HER2-negative Breast Cancer Production of Key Manufacturers (2015 and 2016)

Table Global HER2-negative Breast Cancer Production Share by Manufacturers (2015 and 2016)

Figure 2015 HER2-negative Breast Cancer Production Share by Manufacturers

Figure 2016 HER2-negative Breast Cancer Production Share by Manufacturers

Table Global HER2-negative Breast Cancer Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global HER2-negative Breast Cancer Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global HER2-negative Breast Cancer Revenue Share by Manufacturers

Table 2016 Global HER2-negative Breast Cancer Revenue Share by Manufacturers

Table Global Market HER2-negative Breast Cancer Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market HER2-negative Breast Cancer Average Price of Key Manufacturers in 2015

Table Manufacturers HER2-negative Breast Cancer Manufacturing Base Distribution and Sales Area

Table Manufacturers HER2-negative Breast Cancer Product Type

Figure HER2-negative Breast Cancer Market Share of Top 3 Manufacturers

Figure HER2-negative Breast Cancer Market Share of Top 5 Manufacturers

Table Global HER2-negative Breast Cancer Production by Regions (2011-2016)

Figure Global HER2-negative Breast Cancer Production and Market Share by Regions (2011-2016)

Figure Global HER2-negative Breast Cancer Production Market Share by Regions (2011-2016)

Figure 2015 Global HER2-negative Breast Cancer Production Market Share by Regions

Table Global HER2-negative Breast Cancer Revenue by Regions (2011-2016)

Table Global HER2-negative Breast Cancer Revenue Market Share by Regions (2011-2016)

Table 2015 Global HER2-negative Breast Cancer Revenue Market Share by Regions

Table Global HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Table North America HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Table China HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Table India HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Table Global HER2-negative Breast Cancer Consumption Market by Regions (2011-2016)

Table Global HER2-negative Breast Cancer Consumption Market Share by Regions (2011-2016)

Figure Global HER2-negative Breast Cancer Consumption Market Share by Regions (2011-2016)

Figure 2015 Global HER2-negative Breast Cancer Consumption Market Share by Regions

Table North America HER2-negative Breast Cancer Production, Consumption, Import & Export (2011-2016)

Table Europe HER2-negative Breast Cancer Production, Consumption, Import & Export (2011-2016)

Table China HER2-negative Breast Cancer Production, Consumption, Import & Export (2011-2016)

Table Japan HER2-negative Breast Cancer Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia HER2-negative Breast Cancer Production, Consumption, Import & Export (2011-2016)

Table India HER2-negative Breast Cancer Production, Consumption, Import & Export (2011-2016)

Table Global HER2-negative Breast Cancer Production by Type (2011-2016)

Table Global HER2-negative Breast Cancer Production Share by Type (2011-2016)

Figure Production Market Share of HER2-negative Breast Cancer by Type (2011-2016)

Figure 2015 Production Market Share of HER2-negative Breast Cancer by Type

Table Global HER2-negative Breast Cancer Revenue by Type (2011-2016)

Table Global HER2-negative Breast Cancer Revenue Share by Type (2011-2016)

Figure Production Revenue Share of HER2-negative Breast Cancer by Type (2011-2016)

Figure 2015 Revenue Market Share of HER2-negative Breast Cancer by Type

Table Global HER2-negative Breast Cancer Price by Type (2011-2016)

Figure Global HER2-negative Breast Cancer Production Growth by Type (2011-2016)

Table Global HER2-negative Breast Cancer Consumption by Application (2011-2016)

Table Global HER2-negative Breast Cancer Consumption Market Share by Application (2011-2016)

Figure Global HER2-negative Breast Cancer Consumption Market Share by Application in 2015

Table Global HER2-negative Breast Cancer Consumption Growth Rate by Application (2011-2016)

Figure Global HER2-negative Breast Cancer Consumption Growth Rate by Application (2011-2016)

Table F. Hoffmann-La Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table F. Hoffmann-La Roche HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure F. Hoffmann-La Roche HER2-negative Breast Cancer Market Share (2011-2016)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis HER2-negative Breast Cancer Market Share (2011-2016)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer HER2-negative Breast Cancer Market Share (2011-2016)

Table AbbVie Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AbbVie HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure AbbVie HER2-negative Breast Cancer Market Share (2011-2016)

Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AstraZeneca HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure AstraZeneca HER2-negative Breast Cancer Market Share (2011-2016)

Table BioMarin Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table BioMarin HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure BioMarin HER2-negative Breast Cancer Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bristol-Myers Squibb HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol-Myers Squibb HER2-negative Breast Cancer Market Share (2011-2016)

Table Eisai Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eisai HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure Eisai HER2-negative Breast Cancer Market Share (2011-2016)

Table Eli Lilly Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure Eli Lilly HER2-negative Breast Cancer Market Share (2011-2016)

Table Galena Biopharma Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Galena Biopharma HER2-negative Breast Cancer Production, Revenue, Price and Gross Margin (2011-2016)

Figure Galena Biopharma HER2-negative Breast Cancer Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of HER2-negative Breast Cancer

Figure Manufacturing Process Analysis of HER2-negative Breast Cancer

Figure HER2-negative Breast Cancer Industrial Chain Analysis

Table Raw Materials Sources of HER2-negative Breast Cancer Major Manufacturers in 2015

Table Major Buyers of HER2-negative Breast Cancer

Table Distributors/Traders List

Figure Global HER2-negative Breast Cancer Production and Growth Rate Forecast (2016-2021)

Figure Global HER2-negative Breast Cancer Revenue and Growth Rate Forecast (2016-2021)

Table Global HER2-negative Breast Cancer Production Forecast by Regions (2016-2021)

Table Global HER2-negative Breast Cancer Consumption Forecast by Regions (2016-2021)

Table Global HER2-negative Breast Cancer Production Forecast by Type (2016-2021)

Table Global HER2-negative Breast Cancer Consumption Forecast by Application (2016-2021)